http://www.modernmedicine.com/modernmedicine/Psoriasis/Article/list/40161 Looking for medical articles about Psoriasis? Modern Medicine has the information you need to stay industry current. Subscribe today. 2009-11-21T20:53:06Z http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Embryonic-Stem-Cells-Show-Potential-for-Skin-Subst/ArticleNewsFeed/Article/detail/643215?contextCategoryId=40161&ref=25 Human embryonic stem cells can be used to create a stratified epithelium resembling normal human epidermis, a finding that has potential implications in producing temporary skin replacement for burn patients, according to research published in the Nov. 21 issue of The Lancet. 2009-11-20T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/643215/4132.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/643215null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Study-Investigates-Syndrome-Akin-to-Neurofibromato/ArticleNewsFeed/Article/detail/642513?contextCategoryId=40161&ref=25 A condition recently named Legius syndrome -- associated with SPRED1 mutations -- may be difficult to differentiate from neurofibromatosis type 1 based on dermatologic findings, according to research published in the Nov. 18 issue of the Journal of the American Medical Association. 2009-11-17T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642513/genetics_59175.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472009/642513null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/October-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/638305?contextCategoryId=40161&ref=25 2009-11-02T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452009/638305null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Rough-Microdermabrasion-May-Be-Better-for-Skin-Rem/ArticleNewsFeed/Article/detail/636216?contextCategoryId=40161&ref=25 Using a coarse-grit hand piece to conduct microdermabrasion prompts sun-damaged skin to remodel itself in a process similar to wound healing, and may be more effective in dermal remodeling than medium-grit use, according to a study in the October issue of the Archives of Dermatology. 2009-10-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636216/sun.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/636216null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/ACR-Gleevec-Found-Promising-for-Systemic-Sclerosis/ArticleNewsFeed/Article/detail/635119?contextCategoryId=40161&ref=25 In patients with systemic sclerosis, treatment with imatinib mesylate (Gleevec) may be a safe and effective therapy, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting, held from Oct. 17 to 21 in Philadelphia. 2009-10-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/635119/54184.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432009/635119null XML http://www.modernmedicine.com/modernmedicine/Psoriasis/Organ-Donor-Family-Consent-Request-Protocols-Compa/ArticleNewsFeed/Article/detail/633186?contextCategoryId=40161&ref=25 Organ donation using collaborative requesting instead of routine requesting by a patient's clinician may not provide increases in consent rates, according to an unblinded, multi-center, randomized controlled trial performed in the United Kingdom published Oct. 8 in BMJ. 2009-10-09T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/633186/consent_18260.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/412009/633186null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/September-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/630874?contextCategoryId=40161&ref=25 2009-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402009/630874null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Sclerotic-Skin-Diseases-Often-Have-Psychosocial-Im/ArticleNewsFeed/Article/detail/628122?contextCategoryId=40161&ref=25 The chronic sclerotic skin diseases eosinophilic fasciitis and morphea can be accompanied by physical pain, psychological distress, perceived social stigmatization, and other impacts that combine to impair the patient's quality of life, according to a study in the September issue of the Archives of Dermatology. 2009-09-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/628122/stressedvet.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/392009/628122null XML http://www.modernmedicine.com/modernmedicine/Clinical+Dermatology/rsquoCrystelrsquo-clear-Study-shows-etanercept-imp/ArticleStandard/Article/detail/623639?contextCategoryId=40161&ref=25 International report — Etanercept therapy helps to improve symptoms of depression and anxiety long-term in patients suffering from moderate-to severe psoriasis, according to the results of the Crystel study. 2009-09-02T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/362009/623639null HTML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Golimumab-eases-PsA-Benefits-of-once-monthly-anti-/ArticleStandard/Article/detail/622596?contextCategoryId=40161&ref=25 Results have been analyzed from 276 patients followed for two years in the phase 3 trial of golimumab for the treatment of psoriatic arthritis. The data shows sustained benefits with no new safety signals emerging. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/362009/622596null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/August-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/623303?contextCategoryId=40161&ref=25 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/362009/623303null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/All-systems-go-Association-between-psoriasis-metab/ArticleStandard/Article/detail/622590?contextCategoryId=40161&ref=25 The evidence linking psoriasis to metabolic syndrome and cardiovascular disease is overwhelming, classifying psoriasis as a systemic disease and not simply a disease of the skin. 2009-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/362009/622590null XML http://www.modernmedicine.com/modernmedicine/Dermatology/TNF-blockers-boost-risk-of-lymphoma-FDA-says/ArticleStandard/Article/detail/616609?contextCategoryId=40161&ref=25 Washington — The Food and Drug Administration (FDA) says an increased risk of lymphoma and other cancers is associated with the use of drugs like Remicade (Centocor) and Humira (Abbott) in children and adolescents, the Wall Street Journal reports. 2009-08-05T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616609null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/July-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/616000?contextCategoryId=40161&ref=25 2009-08-03T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/322009/616000null XML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Anti-TNF-safety-Medical-comorbidities-present-psor/ArticleStandard/Article/detail/616247?contextCategoryId=40161&ref=25 As psoriasis patients may have medical comorbidities that would have excluded them from participation in premarketing clinical trials, clinicians must turn to other sources for data to guide therapeutic decisions. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616247null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Unraveling-psoriasis-Basic-science-clinical-resear/ArticleStandard/Article/detail/616251?contextCategoryId=40161&ref=25 Findings from multiple types of studies point to IL-23 as a master cytokine in the pathogenesis of psoriasis. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616251null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Nail-psoriasis-Anti-TNF-agents-safe-effective-in-m/ArticleStandard/Article/detail/616256?contextCategoryId=40161&ref=25 Systemic therapies, particularly anti-tumor necrosis factor (TNF) agents, are an appropriate course of therapy for patients with nail psoriasis. 2009-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/322009/616256/NailsLS006241_flash.jpg XML http://www.modernmedicine.com/modernmedicine/CME+Showcase/Get-under-the-skin/CME/Article/detail/617574?contextCategoryId=40161&ref=25 2009-07-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/cme/memag/322009/617574null REMOTE http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ultrasound-Can-Help-Diagnose-Benign-Skin-Lesions/ArticleNewsFeed/Article/detail/612712?contextCategoryId=40161&ref=25 Ultrasound is a useful tool to diagnose benign subcutaneous lesions and could reduce the number of lesions referred to a hospital for treatment, according to a study published in the July issue of the Archives of Dermatology. 2009-07-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612712/skin_spot.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302009/612712null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Anti-TNF-Monoclonal-Antibody-Therapy-Linked-to-Tub/ArticleNewsFeed/Article/detail/610739?contextCategoryId=40161&ref=25 Anti-tumor necrosis factor monoclonal antibody therapy is associated with a higher risk of tuberculosis than soluble TNF receptor therapy, according to research published in the July issue of Arthritis & Rheumatism. 2009-07-13T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/292009/610739/Tuberculosis.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/292009/610739null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/June-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/608152?contextCategoryId=40161&ref=25 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/608152null XML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Psoriasiss-changing-face-Therapies-understanding-o/ArticleStandard/Article/detail/607907?contextCategoryId=40161&ref=25 Herakleitos, the Greek philosopher from Ephesus, once said, "Ta panta rei," which means "Everything changes and is in a state of flux." Perhaps no other quote better suits the ever-changing theories surrounding the nature, origin and cause of the dermatosis we call psoriasis. 2009-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/272009/607907null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Topical-Fluorouracil-Helps-Treat-Photoaging/ArticleNewsFeed/Article/detail/604064?contextCategoryId=40161&ref=25 Topical fluorouracil can successfully treat actinic keratoses and photodamage by promoting wound healing patterns similar to those caused by laser treatments, according to a study published in the June issue of the Archives of Dermatology. 2009-06-16T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/604064/skin_spot.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/252009/604064null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Maintaining-control-Effective-therapy-improves-qua/ArticleStandard/Article/detail/600535?contextCategoryId=40161&ref=25 Ustekinumab (Centocor) pivotal trial data provide further evidence of the quality-of-life benefits derived when patients with moderate-to-severe psoriasis can maintain disease control. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/222009/600535null XML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Treating-psoriatic-arthritis-One-year-data-positiv/ArticleStandard/Article/detail/600526?contextCategoryId=40161&ref=25 The investigational anti-tumor necrosis factor (TNF) monoclonal antibody golimumab (Centocor) is being evaluated as a once-a-month subcutaneous injection for the treatment of psoriatic arthritis in a Phase 3 trial that enrolled approximately 400 patients. 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/222009/600526/psoriatic_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Pathology/May-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/600974?contextCategoryId=40161&ref=25 2009-06-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/232009/600974null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Home-UVB-Therapy-Is-Feasible-for-Psoriasis-Patient/ArticleNewsFeed/Article/detail/597336?contextCategoryId=40161&ref=25 In patients with mild-to-severe psoriasis, home-based and clinic-based ultraviolet B (UVB) phototherapy are equally safe and effective, but home-based therapy may be associated with greater patient satisfaction, according to a study published online May 7 in BMJ. 2009-05-08T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/192009/597336/psoriasis.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/192009/597336null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Pediatric-psoriasis-C-reactive-protein-levels-asso/ArticleStandard/Article/detail/596316?contextCategoryId=40161&ref=25 Recent study results indicate that there is a relationship between the severity of psoriasis and CRP levels, as well as BMI in pediatric patients. These patients are also at a higher cardiovascular risk, begging the need for treatment strategies in terms of lipid-lowering therapies. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596316null XML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Etanercept-beats-psoriasis-Biologic-therapy-increa/ArticleStandard/Article/detail/596318?contextCategoryId=40161&ref=25 Biologic therapy is proven to increase the quality of life in adult patients suffering from moderate-to-severe psoriasis. A recent study shows that etanercept (Enbrel, Immunex) can achieve similar positive results in children and adolescents, offering hope to this patient population. 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/182009/596318null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/April-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/596178?contextCategoryId=40161&ref=25 2009-05-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/182009/596178null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/In-Office-Visit-Offers-Benefits-Compared-to-Telede/ArticleNewsFeed/Article/detail/594918?contextCategoryId=40161&ref=25 In general, the use of teledermatology resulted in poorer diagnostic accuracy when evaluating nonpigmented lesions than clinic-based dermatology, according to research published in the April issue of the Journal of the American Academy of Dermatology. 2009-04-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/172009/594918/doctorwriting_18136.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/172009/594918null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Psoriasis-Associated-With-Higher-Diabetes-Risk/ArticleNewsFeed/Article/detail/594450?contextCategoryId=40161&ref=25 Patients with psoriasis are more likely to have diabetes and hypertension compared to their counterparts without the skin condition, according to a study published in the April issue of the Archives of Dermatology. 2009-04-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/172009/594450/psoriasis.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/172009/594450null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Disturbed-Sleep-Common-in-Patients-With-Psoriasis/ArticleNewsFeed/Article/detail/593950?contextCategoryId=40161&ref=25 In patients with psoriasis, psoriatic arthritis and several other factors are predictors of sleep interference, according to a study published in the April issue of the Journal of the American Academy of Dermatology. 2009-04-17T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593950/psoriasis2.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/162009/593950null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Avoterim-May-Speed-Healing-Reduce-Scarring/ArticleNewsFeed/Article/detail/593029?contextCategoryId=40161&ref=25 Transforming growth factor β3 (TGFβ3), also known as avotermin, significantly improved the appearance of scars in both the short term and long term in a series of three studies conducted in the United Kingdom, according to research published in the April 11 issue of The Lancet. 2009-04-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/593029/bandage_18005.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/593029null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Golimumab-Linked-to-Psoriatic-Arthritis-Improvemen/ArticleNewsFeed/Article/detail/592968?contextCategoryId=40161&ref=25 Golimumab, a human monoclonal antibody against tumor necrosis factor alpha, showed benefits in adults with psoriatic arthritis, according to research published in the April issue of Arthritis & Rheumatism. 2009-04-10T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/592968/ARTHRITIS.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/592968null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Complications-Linked-to-Laser-Skin-Resurfacing/ArticleNewsFeed/Article/detail/591829?contextCategoryId=40161&ref=25 Severe dermatologic complications can develop in patients who undergo fractional CO2 laser resurfacing, according to a study published online March 16 in Lasers in Surgery and Medicine. 2009-04-06T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/591829/wrinkles.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/152009/591829null XML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Medical-advances-New-research-promises-novel-thera/ArticleStandard/Article/detail/592572?contextCategoryId=40161&ref=25 Advances in pediatric inflammatory skin diseases, such as psoriasis, acne and atopic dermatitis, have led to new therapies and better understanding of the underlying disease processes. 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/152009/592572/84438806_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/March-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/590873?contextCategoryId=40161&ref=25 2009-04-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/272009/590873null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/American-Academy-of-Dermatology-March-6-10-2009/ArticleNewsFeed/Article/detail/588938?contextCategoryId=40161&ref=25 2009-03-23T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/132009/588938null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Low-Dose-Acitretin-Shown-Effective-in-Nail-Psorias/ArticleNewsFeed/Article/detail/587664?contextCategoryId=40161&ref=25 Acitretin, a medication historically prescribed for skin psoriasis, is comparable to the biologic drugs adalimumab and infliximab in clearing up nail psoriasis, according to the results of a clinical trial reported in the March issue of the Archives of Dermatology. 2009-03-17T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/122009/587664/ss39026.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/122009/587664null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAD-Newer-Therapies-Show-Promise-for-Atopic-Dermat/ArticleNewsFeed/Article/detail/585871?contextCategoryId=40161&ref=25 An array of new targeted therapies may bring relief to the many children and adults in the United States who experience chronic atopic dermatitis, according to research presented at the 67th Annual Meeting of the American Academy of Dermatology held Mar. 6 to 10 in San Francisco. 2009-03-09T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/585871/54150.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/585871null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/AAD-Novel-Therapy-Effective-for-Scleroderma-Skin-U/ArticleNewsFeed/Article/detail/585952?contextCategoryId=40161&ref=25 A combination therapy involving stem cells and bioengineered skin shows promise in the treatment of hard-to-heal skin ulcers in scleroderma patients, according to preliminary research presented at the 67th Annual Meeting of the American Academy of Dermatology held Mar. 6 to 10 in San Francisco. 2009-03-09T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/585952/scleroderma.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/112009/585952null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/AAD-Severe-pediatric-skin-disease/ArticleStandard/Article/detail/585699?contextCategoryId=40161&ref=25 San Francisco — Children with skin diseases such as severe psoriasis, eczema and hemangiomas are benefiting from new treatments and new knowledge about existing treatments, experts say. 2009-03-07T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585699null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Conference+News/AAD-Old-but-still-good/ArticleStandard/Article/detail/585525?contextCategoryId=40161&ref=25 San Francisco — Phototherapy still plays a very useful role in the dermatologist’s treatment armamentarium, despite therapeutic advances and the advent of biologic drugs for treating many skin diseases, said Michael D. Zanolli, M.D., of Nashville, Tenn., who spoke Friday at the 67th Annual Meeting of the American Academy of Dermatology here. 2009-03-06T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585525null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/February-2009-Briefing---Dermatology/ArticleNewsFeed/Article/detail/584203?contextCategoryId=40161&ref=25 2009-03-02T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/272009/584203null XML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Coal-tar-soothes-psoriasis-New-formulation-effecti/ArticleStandard/Article/detail/585614?contextCategoryId=40161&ref=25 A new coal tar treatment for psoriasis sidesteps major formulation challenges that hindered patient acceptance of previous coal tar products, a clinical investigator says. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585614null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Calcitriol-Vectical-Vitamin-D-analogue-approved-fo/ArticleStandard/Article/detail/584583?contextCategoryId=40161&ref=25 New formulation: Calcitriol (Vectical), a Vitamin D analogue, was approved on January 23, 2009, for the treatment of mild-to-moderate plaque psoriasis 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/formulary/102009/584583null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ustekinumab-A-human-monoclonal-antibody-for-the-tr/ArticleStandard/Article/detail/584587?contextCategoryId=40161&ref=25 Ustekinumab is a novel investigational human monoclonal antibody (mAb) that is pending approval for the treatment of plaque psoriasis. Subcutaneous administration of ustekinumab has demonstrated efficacy in both phase 2 and 3 trials. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/formulary/102009/584587null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Quality-of-life-Combination-therapy-improves-contr/ArticleStandard/Article/detail/585621?contextCategoryId=40161&ref=25 Combination therapy has a role in the treatment of psoriasis, particularly when there is a loss of response with monotherapy using biologic agents. Methotrexate, systemic retinoids, or phototherapy can be part of a combined therapy with biologic agents. 2009-03-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/102009/585621null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Tacrolimus-Corticosteroid-Regimen-May-Improve-Derm/ArticleNewsFeed/Article/detail/583862?contextCategoryId=40161&ref=25 A sequential regimen of tacrolimus ointment and tapered use of topical corticosteroids in children may provide control of atopic dermatitis while limiting exposure to corticosteroids, according to research published in the February issue of the Journal of the American Academy of Dermatology. 2009-02-27T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583862/13520038.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583862null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Osteopontin-May-Be-Heart-Risk-Factor-in-Psoriasis-/ArticleNewsFeed/Article/detail/583400?contextCategoryId=40161&ref=25 Circulating osteopontin -- a glycophosphoprotein secreted by epithelial and many other cell types -- may be a cardiovascular risk factor in individuals with psoriasis, according to research published in the February issue of the Journal of the American Academy of Dermatology. 2009-02-25T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583400/psoriasis2.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583400null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Black-Women-Face-Higher-Risk-of-Early-Mycosis-Fung/ArticleNewsFeed/Article/detail/583034?contextCategoryId=40161&ref=25 Women are more likely than men to present with mycosis fungoides -- the most common type of cutaneous T-cell lymphoma -- before the age of 40, as are black and Hispanic patients, according to research published in the February issue of the Journal of the American Academy of Dermatology. 2009-02-23T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583034/blackwoman_33122.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/092009/583034null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Rare-Brain-Infection-Confirmed-in-Patients-on-Efal/ArticleNewsFeed/Article/detail/582764?contextCategoryId=40161&ref=25 Three cases of progressive multifocal leukoencephalopathy (PML) have been confirmed in patients taking the psoriasis drug efalizumab (Raptiva), according to a public health advisory issued by the U.S. Food and Drug Administration on Feb. 19. 2009-02-20T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/272009/582764/33105.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/272009/582764null XML http://www.modernmedicine.com/modernmedicine/Research+Briefs/FDA-warns-of-psoriatic-PML-risk-with-Raptiva/ArticleStandard/Article/detail/581124?contextCategoryId=40161&ref=25 Washington — The Food and Drug Administration is warning patients on the psoriasis drug Raptiva (Genentech) about the risk of developing progressive multifocal leukoencephatolopathy (PML), the Wall Street Journal reports. 2009-02-19T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/072009/581124null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Ocular-Damage-Common-in-Severe-Skin-Reactions/ArticleNewsFeed/Article/detail/582431?contextCategoryId=40161&ref=25 It is common for patients with the rare skin reactions toxic epidermal necrolysis or Stevens-Johnson syndrome to also experience involvement of the eyes, according to the results of a study published in the February issue of the Archives of Dermatology. 2009-02-18T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582431/eye_40179.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582431null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Predeployment-Skin-Checks-Can-Reduce-Skin-Disease-/ArticleNewsFeed/Article/detail/582353?contextCategoryId=40161&ref=25 The number of aeromedical evacuations conducted by the military for patients with ill-defined skin diseases could be reduced if combatants with chronic skin diseases were identified prior to deployment, according to a study published in the February issue of the Archives of Dermatology. 2009-02-18T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582353/soldiers.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/082009/582353null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Interleukin-Based-Psoriatic-Arthritis-Drug-Shows-P/ArticleNewsFeed/Article/detail/581240?contextCategoryId=40161&ref=25 Ustekinumab, a human interleukin 12/23 monoclonal antibody drug, reduces symptoms of psoriatic arthritis and the severity of skin lesions, according to research published online Feb. 12 in The Lancet. 2009-02-12T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/581240/psoriasis.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/072009/581240null XML http://www.modernmedicine.com/modernmedicine/Industry+News/FDA-approves-Vectical-for-treatment-of-mild-to-mod/ArticleStandard/Article/detail/579879?contextCategoryId=40161&ref=25 National report — The Food and Drug Administration has approved Vectical (Galderma), an ointment containing calcitriol, for the treatment of mild-to-moderate psoriasis, according to WebMD. 2009-02-05T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/062009/579879null HTML http://www.modernmedicine.com/modernmedicine/E-newsletter/Researchers-discover-genetic-markers-linked-to-pso/ArticleStandard/Article/detail/578498?contextCategoryId=40161&ref=25 Ann Arbor, Mich. - Researchers have found DNA "hotspots" that highlight the role of certain genes in orchestrating immune responses that cause psoriasis, according to a study published in Nature Genetics. 2009-02-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/052009/578498null HTML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Psoriatic-nails-Study-supports-intramatrix-triamci/ArticleStandard/Article/detail/578202?contextCategoryId=40161&ref=25 A new study supports the use of intramatrix injections of triamcinolone acetonide — particularly at doses of 10 mg/ml — for treating nail psoriasis, a study co-author says. 2009-02-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/052009/578202/before_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Rapidly-Changing-Moles-Associated-with-Sun-Tan-Jab/ArticleNewsFeed/Article/detail/578128?contextCategoryId=40161&ref=25 An untested, injectable drug that is sold on the Internet for its tanning properties is associated with rapidly changing moles, according to an article published online Jan. 27 in BMJ. 2009-01-28T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/052009/578128/sunbather_46292.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/052009/578128null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Psoriasis-Support-Sites-Linked-to-Perceived-Improv/ArticleNewsFeed/Article/detail/576373?contextCategoryId=40161&ref=25 Virtual communities of psoriasis patients allow users to benefit from educational resources as well as psychological and social support systems, researchers report in the January issue of the Archives of Dermatology. 2009-01-20T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/042009/576373/carpaltunnel.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/042009/576373null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Engineered-Skin-Improves-Healing-of-Burn-Wounds/ArticleNewsFeed/Article/detail/576227?contextCategoryId=40161&ref=25 Tissue-engineered skin made from stem cells improves wound healing in a pig burn model, according to a study published online Dec. 22 in Artificial Organs. 2009-01-19T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/042009/576227/stove_fire.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/042009/576227null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Increased-Mortality-Linked-to-Topical-Retinoid-Usa/ArticleNewsFeed/Article/detail/576228?contextCategoryId=40161&ref=25 Topical tretinoin, a frequently prescribed retinoid cream, is associated with increased all-cause mortality, according to study results published in the January issue of the Archives of Dermatology. 2009-01-19T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/042009/576228/doctor_40312.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/042009/576228null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Conference+News/Conference-News-Biologic-therapies/ArticleStandard/Article/detail/576010?contextCategoryId=40161&ref=25 Kohala Coast, HI — In weighing the safety of biological therapies for psoriasis, one of the most fundamental concepts to consider is that psoriasis itself is unsafe, said Kim A. Papp, M.D., Ph.D., at the Winter Clinical Dermatology Conference. 2009-01-18T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/042009/576010null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+Conference+News/Conference-News-Advances-in-biologics/ArticleStandard/Article/detail/576000?contextCategoryId=40161&ref=25 Kohala Coast, HI — An up-and-coming drug from Abbott Laboratories may offer great promise in the treatment of moderate to severe plaque psoriasis, according to Mark Lebwohl, M.D., chairman of the Department of Dermatology at the Mount Sinai School of Medicine. 2009-01-17T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/032009/576000null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/Conference-News-Topical-therapy-update/ArticleStandard/Article/detail/575998?contextCategoryId=40161&ref=25 Kohala Coast, HI — Topical therapy continues to be a mainstay in dermatologic therapy, and innovative products and therapeutic approaches are needed because compliance with traditional topical regimens is poor, said Alan B. Fleischer, Jr, MD, at this year's Winter Clinical Dermatology Conference. 2009-01-17T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/032009/575998null HTML http://www.modernmedicine.com/modernmedicine/E-newsletter/FDA-holds-off-decision-on-psoriasis-drug/ArticleStandard/Article/detail/573220?contextCategoryId=40161&ref=25 New York - The Food and Drug Administration (FDA) has held off making a decision on the psoriasis drug ustekinumab (Johnson & Johnson), until they receive certain risk-mitigation information, but will not require new studies, Reuters reports. 2009-01-06T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/012008/573220null HTML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Resistant-psoriasis-Lifelong-therapies-increase-ri/ArticleStandard/Article/detail/573439?contextCategoryId=40161&ref=25 Psoriasis patients treated for many years with PUVA therapy may be more susceptible to develop cutaneous carcinomas, such as basal cell carcinoma, especially when combined with short regimens of cyclosporine A. Physicians who must turn to this combination regimen in therapy-resistant psoriasis patients should be aware of the possible increased risk for the development of skin cancers in these patients. 2009-01-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/012008/573439null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/December-2008-Briefing---Dermatology/ArticleNewsFeed/Article/detail/573553?contextCategoryId=40161&ref=25 2009-01-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/573553null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/IL-21-and-Receptor-Appear-to-Play-Atopic-Dermatiti/ArticleNewsFeed/Article/detail/572217?contextCategoryId=40161&ref=25 Expression of the cytokine IL-21 and its receptor, IL-21R, is upregulated in skin lesions of atopic dermatitis in humans and also in a mouse model of allergic skin inflammation, according to research published online Dec. 15 in the Journal of Clinical Investigation. 2008-12-17T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/512008/572217/hch080.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/512008/572217null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Psoriasis-Associated-with-Higher-Risk-of-Hyperlept/ArticleNewsFeed/Article/detail/572220?contextCategoryId=40161&ref=25 Psoriasis has been linked to hyperleptinemia, which in turn is associated with a higher risk of developing metabolic syndrome, according to research published in the December issue of the Archives of Dermatology. 2008-12-17T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/512008/572220/psoriasis2.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/512008/572220null XML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/Psoriasis-amp-SCC-Adalimumab-acitretin-control-PUV/ArticleStandard/Article/detail/570119?contextCategoryId=40161&ref=25 The dramatic improvement of a psoriasis patient who had developed squamous cell carcinoma secondary to PUVA treatment illustrates that adalimumab and acitretin work synergistically, a physician familiar with the case says. 2008-12-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/492008/570119null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/November-2008-Briefing---Dermatology/ArticleNewsFeed/Article/detail/568749?contextCategoryId=40161&ref=25 2008-12-01T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/492008/568749null XML http://www.modernmedicine.com/modernmedicine/Pathology/Chinese-Herb-Reduces-Plaque-Psoriasis-Lesions/ArticleNewsFeed/Article/detail/567395?contextCategoryId=40161&ref=25 Topical application of an ointment containing the herb indigo naturalis is a safe and effective treatment for chronic plaque psoriasis, according to research published in the November issue of the Archives of Dermatology. 2008-11-20T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472008/567395/psoriasis.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/472008/567395null XML http://www.modernmedicine.com/modernmedicine/Locum+Tenens/FDA-modifies-labeling-for-psoriasis-drug-amidst-co/ArticleStandard/Article/detail/564481?contextCategoryId=40161&ref=25 Last month, the FDA made labeling changes to psoriasis medication Raptiva (efalizumab), following reports of acute infections resulting in hospitalizations and even deaths in patients taking the drug. A once-a-week injection, Raptiva is used to treat moderate to severe plaque psoriasis in adults who qualify for systemic therapy or phototherapy to manage their psoriasis. 2008-11-13T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/locumlife/452008/564481null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/October-2008-Briefing---Dermatology/ArticleNewsFeed/Article/detail/562849?contextCategoryId=40161&ref=25 2008-11-03T05:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/452008/562849null XML http://www.modernmedicine.com/modernmedicine/Psoriasis+Top+Story/The-obesity-factor-Researchers-study-psoriasis-co-/ArticleStandard/Article/detail/563243?contextCategoryId=40161&ref=25 Etanercept is effective in treating psoriasis in the pediatric population, a study has found. The research also found that patients in the study had increased levels of C-reactive protein, an inflammatory marker that may be elevated as a result of abdominal obesity. 2008-11-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/452008/563243null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Guidelines-for-Psoriatic-Arthritis-Developed/ArticleNewsFeed/Article/detail/561896?contextCategoryId=40161&ref=25 The first guidelines for the diagnosis, assessment and treatment of psoriatic arthritis have been developed, according to an article published online Oct. 24 in Annals of the Rheumatic Diseases. 2008-10-29T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442008/561896/ARTHRITIS.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/442008/561896null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Photodynamic-Therapy-Can-Improve-Sun-Damaged-Skin/ArticleNewsFeed/Article/detail/560247?contextCategoryId=40161&ref=25 The appearance of sun-damaged skin may improve after treatment with photodynamic therapy, according to the results of a study published in the October issue of the Archives of Dermatology. 2008-10-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432008/560247/wrinkles.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/432008/560247null XML http://www.modernmedicine.com/modernmedicine/Medication+Safety/Case-of-PML-reported-in-efalizumab-treated-patient/ArticleStandard/Article/detail/558053?contextCategoryId=40161&ref=25 Genentech informed healthcare professionals that a 70-year-old patient who has been treated with efalizumab (Raptiva) for chronic psoriasis for >4 years has developed progressive multifocal leukoencephalopathy (PML), a rare, progressive disease of the central nervous system that is usually fatal. 2008-10-14T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/formulary/412008/558053null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/September-2008-Briefing---Dermatology/ArticleNewsFeed/Article/detail/555660?contextCategoryId=40161&ref=25 2008-10-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/402008/555660null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Dermatology-Residencies-Need-More-Skin-of-Color-Tr/ArticleNewsFeed/Article/detail/550938?contextCategoryId=40161&ref=25 Dermatology residents in the United States receive relatively little training in treating skin of color, which needs to be improved given that about 48 percent of the U.S. population will be non-white by 2050, according to research published in the October issue of the Journal of the American Academy of Dermatology. 2008-09-17T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382008/550938/black_kids.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382008/550938null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Estradiol-Boosts-Collagen-Production-in-Aged-Skin/ArticleNewsFeed/Article/detail/550332?contextCategoryId=40161&ref=25 In older patients, topical estradiol application appears to stimulate collagen production in sun-protected skin but not in sun-damaged skin, researchers report in the September issue of the Archives of Dermatology. 2008-09-15T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382008/550332/wrinkles.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/382008/550332null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/August-2008-Briefing---Dermatology/ArticleNewsFeed/Article/detail/547072?contextCategoryId=40161&ref=25 2008-09-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/547072null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Laser-Treatment-May-Minimize-Surgical-Scars/ArticleNewsFeed/Article/detail/545154?contextCategoryId=40161&ref=25 In patients with fresh surgical scars, the thermal action of laser treatment may significantly improve the wound healing process and minimize the scars' appearance, according to a pilot study published in the September issue of Lasers in Surgery and Medicine. 2008-08-27T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352008/545154/18072.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352008/545154null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Fractional-Laser-Rejuvenation-Repairs-Sun-Damage/ArticleNewsFeed/Article/detail/545012?contextCategoryId=40161&ref=25 In women with sun-damaged skin, fractional skin rejuvenation may significantly improve wrinkles, skin texture and mottled pigmentation, according to research published in the September issue of Lasers in Surgery and Medicine. 2008-08-26T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352008/545012/45272.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352008/545012null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Pre-Surgical-Cleansing-Procedure-May-Reduce-In/ArticleNewsFeed/Article/detail/544895?contextCategoryId=40161&ref=25 The chlorhexidine shower recommended for reducing the risk of surgical site infections is often impractical for vascular patients due to comorbidities, but an intraoperative surgical site precleansing technique can still help protect them from infections, according to an article published in the August issue of AORN Journal. 2008-08-26T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352008/544895/surgery_40335.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/352008/544895null XML http://www.modernmedicine.com/modernmedicine/E-newsletter/Danish-study-reveals-efficacy-of-combination-thera/ArticleStandard/Article/detail/544848?contextCategoryId=40161&ref=25 Copenhagen, Denmark - Danish researchers have found that combination therapy using betamethasone dipropionate and calcipotriene is more effective for treating scalp psoriasis than either component alone, HealthDay News reports. 2008-08-26T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/352008/544848null HTML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Steroid-Doping-Can-Cause-Severe-Acne-Conglobata/ArticleNewsFeed/Article/detail/543865?contextCategoryId=40161&ref=25 Doping with anabolic steroids -- a common practice in professional and amateur sports -- can cause severe skin lesions that result in permanent scarring, according to an article published in the Aug. 23 issue of The Lancet. 2008-08-22T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/543865/109081.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312009/543865null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Hormone-Therapy-Not-Linked-to-Wrinkle-Improvements/ArticleNewsFeed/Article/detail/543104?contextCategoryId=40161&ref=25 Low-dose hormone therapy doesn't offer statistically significant benefits to postmenopausal women with mild to moderate skin aging changes, researchers report in the September issue of the Journal of the American Academy of Dermatology. 2008-08-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543104/wrinkles.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543104null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Combination-Therapy-Most-Effective-for-Scalp-Psori/ArticleNewsFeed/Article/detail/543106?contextCategoryId=40161&ref=25 A treatment combining betamethasone dipropionate and calcipotriene was more effective for treating scalp psoriasis than either component alone, according to research published in the September issue of the Journal of the American Academy of Dermatology. 2008-08-19T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543106/psoriasis2.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/342008/543106null XML http://www.modernmedicine.com/modernmedicine/Pathology/July-2008-Briefing---Dermatology/ArticleNewsFeed/Article/detail/533302?contextCategoryId=40161&ref=25 2008-08-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/312008/533302null XML http://www.modernmedicine.com/modernmedicine/Pathology/Tuberculosis-Screenings-Urged-for-Psoriasis-Patien/ArticleNewsFeed/Article/detail/531735?contextCategoryId=40161&ref=25 Before psoriasis patients are treated with systemic and biologic agents, they should be screened and treated for latent tuberculosis infections, according to a National Psoriasis Foundation consensus statement published in the August issue of the Journal of the American Academy of Dermatology. 2008-07-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/531735/psoriasis2.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/531735null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/New-Laser-Technique-May-Reduce-Acne-Scars/ArticleNewsFeed/Article/detail/531732?contextCategoryId=40161&ref=25 In patients with acne scars, ablative fractional resurfacing with a novel 30-watt laser that combines carbon dioxide ablation with a fractional photothermolysis system may significantly improve facial appearance with minimal side effects, according to study findings published in the August issue of Lasers in Surgery and Medicine. 2008-07-24T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/531732/Fac075ml.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/531732null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Carbon-Dioxide-Laser-Effective-for-Reducing-Wrinkl/ArticleNewsFeed/Article/detail/531187?contextCategoryId=40161&ref=25 The use of carbon dioxide laser resurfacing for treating facial wrinkles is safe and effective, though hypopigmentation can be a common consequence, according to research published in the July/August issue of the Archives of Facial Plastic Surgery. 2008-07-22T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/531187/wrinkles.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/531187null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Women-More-Likely-Than-Men-to-Remove-Tattoos/ArticleNewsFeed/Article/detail/531084?contextCategoryId=40161&ref=25 Although tattoo procurement is an increasingly mainstream phenomenon, visible tattoos on women may not be as socially acceptable as they are for men, and more women than men choose to have tattoos removed, according to a study published in the July issue of the Archives of Dermatology. 2008-07-21T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/531084/tattoo.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/302008/531084null XML http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Many-Severe-Psoriasis-Patients-Undertreated/ArticleNewsFeed/Article/detail/528244?contextCategoryId=40161&ref=25 Nearly 40 percent of severe psoriasis patients are treated with only topical agents, according to the results of a cross-sectional survey of dermatologists published in the June issue of the Journal of the American Academy of Dermatology. 2008-07-08T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/282008/528244/psoriasis.jpg http://www.modernmedicine.com/modernmedicine/data/articlenewsfeed/modernmedicine/282008/528244null XML http://www.modernmedicine.com/modernmedicine/Psoriasis/Promising-outlook-Study-shows-efalizumab-provides-/ArticleStandard/Article/detail/528095?contextCategoryId=40161&ref=25 The results of a three-year study with efalizumab show that patients with moderate-to-severe psoriasis are able to maintain high PASI scores, reflecting long-term hope for disease-free intervals. 2008-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/282008/528095null XML http://www.modernmedicine.com/modernmedicine/Psoriasis/Express-treatment-Infliximab-maintenance-treatment/ArticleStandard/Article/detail/528094?contextCategoryId=40161&ref=25 The phase 3 EXPRESS II trial data show infliximab (Remicade, Centocor) maintenance treatment with regularly administered infusions is associated with better psoriasis control and fewer infusion reactions than intermittent, as-needed dosing. A composite analysis of infliximab phase 2 and 3 study data shows consistently dramatic improvements across all four body regions evaluated in the studies. 2008-07-01T04:00:00Z http://www.modernmedicine.com/modernmedicine/data/articlestandard/dermatologytimes/282008/528094null XML